Stay updated on Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    22 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and v3.4.3 was removed on the page. This appears to be an administrative version update that does not modify the study details.
    Difference
    0.0%
    Check dated 2026-03-19T04:56:01.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page. No substantive changes to study content or eligibility criteria are indicated.
    Difference
    0.0%
    Check dated 2026-03-12T00:29:33.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed a government funding lapse notice alongside the prior Revision: v3.4.1; these are site maintenance/version updates and do not affect study content, eligibility criteria, or results pages. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:35:16.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Added a government funding notice banner and updated the page revision to v3.4.1, replacing the previous v3.4.0 revision.
    Difference
    0.4%
    Check dated 2026-02-04T10:40:48.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Glossary is now displayed and QC-related metadata (Last Update Submitted that Met QC Criteria) and revision version (v3.4.0) have been added, while the older QC label, No FEAR Act data, and Revision: v3.3.4 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:39:35.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:58:51.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial page.